|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Network parameter estimation using online data with application to transformer tap position estimation显示文摘 | Custem T V Quintana V | 1988 | IEE Proceedings-PartC1988，135，1： | 1 |
| 2 | Phase Ⅲ study of docetaxel and cisplatin plus fluomuracil compared with the 325 study Group 显示文摘 | Van Custem E Moiseyenko VM Tjulandin S | 2006 | J Clin Onco12006，24，31： | 1 |
| 3 | KRAS status and ef- ficacy in the first-line treatment of patients with metastatic color- ectal cancer treated with FOLFIRI with or without cetuximab: the CRYSTAL experience显示文摘 | Van Custem E Lang I D' haens G | 2008 | J Clin Oncol2008，26，： | 1 |
| 4 | Capecitabine (Xeloda), an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: result of a randomized phase Ⅱstudy显示文摘 | Van Custem E Findlay M Osterwalder B | 2000 | J Clin Oncol2000，18，6： | 1 |
| 5 | Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first line therapy for advanced gastric cancer:a report of the V 325 Study Group显示文摘 | Van Custem E Moiseyenko VM Tjulandin SA | | 0，，31： | 1 |
| 6 | Phase Ⅲ study of docetaxel and eisplatin plus fluorouracil compared with cisplatin and fluomuracil as first line therapy for advanced gastric cancer: a report of the V325 Study Group 显示文摘 | Van Custem E Moiseyenko VM Tjulandin S | 2006 | J Clin Oncol2006，24，49： | 1 |
| 7 | Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first line therapy for advanced gastric cancer: a report of the V325 Study Group显示文摘 | Van Custem E Moiseyenko VM Tjulandin S | 2006 | J Clin Oncol2006，24，31： | 1 |
| 8 | Docetaxel(D), cisplatin, 5-fluorouracil (F) for chemotherapynaive patients with metastatic or locally recurrent,unresectable gastric carcinoma:Interim results of a randomized phase Ⅲ trial (V 325)显示文摘 | Ajani JA Van Custem E Moiseyenko FC l | 2003 | Proc Am Soc Cli Clin Oncol2003，22，： | 1 |
| 9 | Docetaxel(D),cisplatin,5-fluorouracil compared to cisplatin,(C)and 5-fluorouracil(F) for chemotherapy-naive patients with metastatic or locally recurrent,unresectable gastric carcinoma:interim result of a randomized phase Ⅲ trail显示文摘 | Ajani JA Van Custem E Moiseyenko FC | 2003 | Proc Am Soc Clin Oncol2003，22，： | 1 |
| 10 | Extended equal area criterion justifications,generalizations,applications显示文摘 | XUE Y CUSTEM T V PAVELLA M R | 1989 | IEEE Transactions on Power Systems1989，4，1： | 1 |
| 11 | Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine显示文摘 | Van CUSTEM E SNOECK R Van RANST M | 1995 | J Med Virol1995，45，： | 1 |
| 12 | An international phase Ⅱ study of cetuximab in combination with oxaliplatin/5-fluomuracil(5-FU)/folinic acid(FA)(FOLFOX24)in the first-line treatment of patients with metastatic colorectal cancer (cRc)expressing epidermal growth factor receptor(EGFR):Preliminary results显示文摘 | Tabemero JM Custem EV Sastre J | 2004 | Proc Am Soc Clin Oncol2004，23，： | 1 |
| 13 | Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first line therapy for advanced gastric cancer: a report Of the V325 study group显示文摘 | Van Custem E Moiseyenko VM Tjulandin S | 2006 | J Clin Oncol2006，24，31： | 1 |
| 14 | Correlation of acne rash and tumor response with cetuximab monotherapy in patients with colorectal refractory to both irinotecan and oxliplatin 显示文摘 | Van Custem E Mayer RJ Gold P | 2004 | Eur J Cancer2004，，2： | 1 |
| 15 | A method to compute reactive power margins with respect to voltage collapse显示文摘 | Custem T V | 1991 | IEEE Trans on Power Systems1991，6，1： | 1 |
| 16 | Docetaxel(D),cisplatin,5-fluorouracil(F)for chemotherapy-naive patients with metastatic or locally recurrent,unresectable gastric carcinoma:Interim results of a randomized phase III trial(V 325)显示文摘 | Ajani JA Van Custem E Moiseyenko FC | | Proc Am Soc Cli0，，： | 1 |
| 17 | A Method of Compute Reactive Power Margins with Respect to Voltage Collapse显示文摘 | CUSTEM | 1991 | IEEE Transactions on Power Systems1991，6，12： | 1 |
| 18 | Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer 显示文摘 | Rougier P Van Custem E Bajetts E | 1998 | Lancet1998，352，9138： | 1 |
| 19 | Correlation of acne rash and tumor response with cetuximab monotherapy in patients with colorectal refractory to both irinotecan and oxliplatin 显示文摘 | Van Custem E Mayer R J Gold P | 2004 | Eur J Cancer2004，，2： | 1 |
| 20 | Synergism of the antimicrobial agents miconazole and benzoylperoxide显示文摘 | BOSSCHE HV CORNELISSEN F CUSTEM JV | 1982 | Br J Dermatol1982，107，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员